|
LOC727896 expression based on
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.186200E-02 |
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.917630E-02 |
| Normal-vs-Stage2 |
5.718300E-02 |
| Normal-vs-Stage3 |
N/A |
| Normal-vs-Stage4 |
2.104500E-02 |
| Stage1-vs-Stage2 |
2.470600E-01 |
| Stage1-vs-Stage3 |
N/A |
| Stage1-vs-Stage4 |
7.240800E-01 |
| Stage2-vs-Stage3 |
N/A |
| Stage2-vs-Stage4 |
1.678030E-01 |
| Stage3-vs-Stage4 |
N/A |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.721600E-02 |
| Normal-vs-AfricanAmerican |
1.061510E-03 |
| Normal-vs-Asian |
8.340100E-03 |
| Caucasian-vs-AfricanAmerican |
7.918000E-02 |
| Caucasian-vs-Asian |
5.571000E-01 |
| AfricanAmerican-vs-Asian |
6.879900E-02 |
|
|
CHOL : Cholangiocarcinoma *
Please note that the TPM values for gene considered is extremely low (TPM < 1).
*
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.636480E-02 |
| Normal-vs-Female |
2.149700E-02 |
| Male-vs-Female |
9.981000E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient BMI information is not available for 1 sample.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.559980E-01 |
| Normal-vs-Extreme_Weight |
5.302000E-02 |
| Normal-vs-Obese |
1.170180E-04 |
| Normal-vs-Extreme_Obese |
N/A |
| Normal_Weight-vs-Extreme_Weight |
8.174800E-01 |
| Normal_Weight-vs-Obese |
2.882000E-02 |
| Normal_Weight-vs-Extreme_Obese |
N/A |
| Extreme_Weight-vs-Obese |
1.407670E-02 |
| Extreme_Weight-vs-Extreme_Obese |
N/A |
| Obese-vs-Extreme_Obese |
N/A |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.322300E-03 |
| Normal-vs-Age(41-60Yrs) |
5.443500E-02 |
| Normal-vs-Age(61-80Yrs) |
1.236390E-02 |
| Normal-vs-Age(81-100Yrs) |
4.831000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.159800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.353200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.063440E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.520600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.131800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.580200E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that the TPM values for gene considered is extremely low (TPM < 1).
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
N/A |
| Normal-vs-Grade 2 |
6.264000E-01 |
| Normal-vs-Grade 3 |
6.910000E-01 |
| Normal-vs-Grade 4 |
1.000000E+00 |
| Grade 1-vs-Grade 2 |
N/A |
| Grade 1-vs-Grade 3 |
N/A |
| Grade 1-vs-Grade 4 |
N/A |
| Grade 2-vs-Grade 3 |
8.424600E-01 |
| Grade 2-vs-Grade 4 |
6.264000E-01 |
| Grade 3-vs-Grade 4 |
6.910000E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that the TPM values for gene considered is extremely low (TPM < 1).
*
Please note that low number(<10) of normal samples considered.
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 5 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.332000E-02 |
| Normal-vs-N1 |
1.261930E-03 |
| N0-vs-N1 |
4.679600E-02 |
|
|
